Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
56.21
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi-Aventis S.A. ADR
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
29
30
Next >
How Is The Market Feeling About Sanofi?
July 20, 2023
Via
Benzinga
Recludix Pharma Enters into a Strategic Collaboration with Sanofi to Advance Novel Oral STAT6 Inhibitor in Multiple Immunological and Inflammatory Indications
July 20, 2023
From
Recludix Pharma, Inc.
Via
GlobeNewswire
NBCUniversal's Peacock Raises Prices First Time Since Launch, Warren Buffett Sells Majority of Activision Blizzard Stake Before Microsoft Deal Approval, Novartis Launches $15B Share Buyback: Today's Top Stories
July 18, 2023
Wall Street Journal
Via
Benzinga
AstraZeneca-Sanofi's Respiratory Syncytial Virus Treatment Scores FDA Approval To Prevent Infection In Infants
July 18, 2023
The FDA approved AstraZeneca Plc (NASDAQ:
Via
Benzinga
Looking Into Sanofi's Recent Short Interest
July 03, 2023
Via
Benzinga
2 Biopharma Stocks Making Big Moves Tuesday
June 20, 2023
Markets looked poised for a pause, but these stocks didn't stand still.
Via
The Motley Fool
2 Best Biotech Stocks to Buy Right Now
June 16, 2023
These international-based pharmaceutical companies pay market-topping dividends to shareholders.
Via
The Motley Fool
Phase 1 Results Are "Extraordinary," Says Chairman Of Scientific Advisory Board As Biomedical Company Preps Phase 2 Trial For MS Treatment
July 17, 2023
Tiziana Life Sciences (NASDAQ: TSLA) has presented data from its clinical trial showing that five of its six patients with an advanced stage of multiple sclerosis (MS) have shown a reduction in...
Via
Benzinga
Is Affordable Insulin Available? Survey Reveals Uninsured Americans Paying More Despite Promised Price Reduction
July 13, 2023
According to a survey conducted by U.S.
Via
Benzinga
Why Shares of Exscientia Jumped on Wednesday
July 12, 2023
The company may be riding the wave of an AI healthcare boom.
Via
The Motley Fool
Takeda Withdraws FDA Application For Dengue Vaccine Candidate On Data Disagreement
July 12, 2023
Takeda Pharmaceutical Co Ltd (NYSE: TAK) said on Tuesday that it was voluntarily
Via
Benzinga
Publications And Positive Data From Multiple Trials: Six Months In Review For Tiziana Life Sciences (NASDAQ: TLSA)
July 10, 2023
Tiziana Life Sciences (NASDAQ: TLSA) is a biotechnology company establishing itself in a cutting-edge position in the market with its breakt
Via
Benzinga
Was This $3 Billion Deal a Wise Move for Sanofi?
May 31, 2023
The French drugmaker appears to have meaningfully improved its portfolio with the acquisition.
Via
The Motley Fool
Evotec Secures US Government Contract For Orthopoxvirus Antibody
July 05, 2023
The U.S.
Via
Benzinga
First US Trial Over Zantac's Alleged Cancer-Causing Properties Set For November In California
July 03, 2023
The initial U.S. court trial concerning the antacid medication Zantac is slated to commence on November 13 in a state court in California, as stated by a lawyer representing the plaintiffs.
Via
Benzinga
Sanofi's Amlitelimab Hits Primary Goal In Mid-Stage Atopic Dermatitis Study
June 27, 2023
Sanofi SA (NASDAQ: SNY) says its Phase 2b study (STREAM-AD) of amlitelimab for adults with moderate-to-severe atopic dermatitis, who cannot adequately manage their condition with topical medications,...
Via
Benzinga
AI Stocks: C3.ai, Palantir Pull Back Amid HPE, Cybersecurity, Cloud AI News
June 23, 2023
The big rally in AI stocks may finally be taking a break but the steady drumbeat in artificial intelligence news continues.
Via
Investor's Business Daily
GSK Confidentially Settles First Zantac-Associated Cancer Lawsuit Due For US Trial Next Month
June 23, 2023
GSK plc (NYSE: GSK) has reached a confidential settlement with James Goet
Via
Benzinga
European Drug Authority Raises Thyroid Cancer Safety Signal For Novo Nordisk Drugs, Including Hyped Semaglutide
June 22, 2023
The EU's drugs watchdog, the European Medicines Agency, recently raised a thyroid cancer safety signal for Novo Nordisk A/S (NYSE: NVO) drugs, including the much talked semaglutide used i
Via
Benzinga
Spotify to Launch New Expensive Subscription Plan, Chinese Vendors Bypass US Embargo to Supply Nvidia AI Chips, Eddie Wu To Succeed Daniel Zhang As Alibaba's CEO: Today's Top Stories
June 20, 2023
Bloomberg
Via
Benzinga
Sanofi Stock Is Trading Higher Today - Here's Why
June 20, 2023
Sanofi SA (NASDAQ: SNY) announced that the tribunal dismissed Boehringer Ingelheim's indemnification claim against Sanofi in an International Chamber of Commerce dispute in cancer lawsuits linked to...
Via
Benzinga
Tiziana Life Sciences (NASDAQ: TLSA) Announces Positive Data In Its Secondary-Progressive Multiple Sclerosis Trial, What Could This Mean For The Company?
June 15, 2023
Company Moves Ahead With Drug Development
Via
Benzinga
DarioHealth is an AI-Powered Digital Therapeutics Play
June 13, 2023
DarioHealth Co. (NASDAQ: DRIO) is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Netflix Gains Subs From Password Sharing Crackdown, Mark Zuckerberg Discusses AI at Latest Employee Met, Privacy Breach Risk in Nvidia's AI Technology Stirs Concern: Today's Top Stories
June 09, 2023
Financial Times
Via
Benzinga
Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon
June 09, 2023
The FDA's Antimicrobial Drugs Advisory Committee has voted unanimously 21 to 0 that AstraZeneca plc (NASDAQ: AZN) and Sanofi SA's (NASDAQ: SNY) nirsevimab has a favorable benefit-risk profile t
Via
Benzinga
Why Shares of Innate Pharma Jumped Thursday
June 08, 2023
The company's collaboration agreement with Sanofi could soon pay off.
Via
The Motley Fool
The 7 Most Reliable Dividend Stocks to Buy Now
June 06, 2023
Faced with a tricky market backdrop, investors may take significant comfort with the most reliable dividend stocks to buy.
Via
InvestorPlace
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
3 Biotech Stocks to Avoid Like the Plague
May 23, 2023
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs.
Via
InvestorPlace
Sanofi-Regeneron Highlight Dupixent Data, Say Drug Benefit Was Swift, Sustained
May 22, 2023
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.